Interstitial lung diseases (ILDs) are a heterogeneous group of disorders characterized by inflammation and/or fibrosis.1Â Pulmonary fibrosis develops due to repeated cycles of injury and impaired repair with fibroblast activation and migration with the resultant deposition of extracellular matrix ...
Lung cancer accounts for the highest cancer-related mortality and is the second most common cause of malignancy worldwide.1Â Diagnosis at an early stage (ES) has a direct effect on management and survival rates. Overall, the 5-year survival rate from 2013 to 2019 ...
Lung cancer remains the leading cause of cancer-related death.1Â However, five-year survival in lung cancer varies greatly based on the stage of the disease at diagnosis.2Â Early lung cancer diagnosis through screening with low-dose computed tomography (CT) demonstrated a 20% reduction ...
Electronic nicotine delivery systems, colloquially referred to as e-cigarettes (ECs), or vaping products were introduced in the US market in 2007 as an alternative to cigarette smoking. They were marketed as a better alternative to nicotine replacement therapy for stopping cigarette ...
Assessment of peripheral pulmonary nodules and mediastinal lymph nodes is critical in the diagnosis and staging of lung cancer, which is the leading cause of cancer death worldwide.1,2 Endobronchial ultrasound (EBUS) continues to evolve, allowing clinicians the ability to evaluate ...
Login
Sign Up FREE
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.